Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis

Wenjie Lu1, Li Yang1, Xiong Li2,3

  • 1Department of Hematology, Wuhan Children's Hospital (Wuhan Medical Care Center for Women and Children), Tongji College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

BMC Pediatrics
|April 18, 2021
PubMed

Insights

Early diagnosis of severe COVID-19 in children is possible by monitoring immune cell counts and inflammatory markers. Key indicators include decreased T lymphocytes and increased interleukin-6 (IL-6) and interleukin-10 (IL-10) levels.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Virology

Background:

  • Early diagnostic indicators for severe or critical COVID-19 in children remain unclear.
  • Understanding immune characteristics of early SARS-CoV-2 infection in children is crucial for prognosis.

Purpose of the Study:

  • To investigate immune characteristics of early SARS-CoV-2 infection in children.
  • To identify prognostic factors for early detection of critical COVID-19 in pediatric patients.

Main Methods:

  • Retrospective study of 121 children with COVID-19.
  • Analysis of peripheral blood lymphocyte subsets, T cell-derived cytokines, inflammatory factors, and routine blood counts at initial presentation.

Main Results:

  • Decreased T lymphocyte subsets and natural killer cells correlated with disease severity.
  • Increased levels of IL-6, IL-10, SAA, and procalcitonin were observed with increasing severity.
  • Reduced hemoglobin, RBC, and eosinophil counts were associated with more severe disease.

Conclusions:

  • Decreased T, Th, Tc cells, RBC, and hemoglobin, along with increased IL-6 and IL-10, are valuable early diagnostic indices for severe pediatric COVID-19.
  • Significantly reduced Th/Tc cells and elevated IL-6, IL-10, ferritin, procalcitonin, and SAA in critical cases suggest immune dysregulation and cytokine storm.
Abstract